Skip Ribbon Commands
Skip to main content
Skip over global navigation links
U.S. Department of Health and Human Services

GenMark Diagnostics, Inc. – ePlex Respiratory Pathogen Panel 2

ASPR’s Portfolio of COVID-19 Medical Countermeasures under EUA

An expanded version of GenMarks’s FDA cleared ePlex Respiratory Pathogen (RP) Panel to include assays for the simultaneous detection of SARS-CoV-2 and other respiratory pathogens.

Emergency Use Authorization

On October 7, 2020, FDA issued an Emergency Use Authorization (EUA) to allow GenMark Diagnositcs, Inc.’s ePlex Respiratory Pathogen Panel 2 to be used to detect and/or diagnose the virus that causes COVID-19.


  • This page last reviewed: October 26, 2020